Global Endowment Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-19,700
Closed -$3.39M 237
2017
Q2
$3.39M Buy
+19,700
New +$3.2M 0.46% 31
2017
Q1
Sell
-19,400
Closed -$2.84M 246
2016
Q4
$2.84M Buy
+19,400
New +$2.92M 0.44% 38

Other funds holding AMGN

Global Endowment Management's AMGN Position: Q3 2017 in Review

Global Endowment Management sold out of Amgen (AMGN) in Q3 2017, closing a stake of 19,700 shares — an estimated $3.39M sold.

Global Endowment Management first reported a position in AMGN in Q4 2016 and held it in 2 quarters. The position peaked at $3.39M in Q2 2017. 1,605 funds tracked by Wall St. Rank hold AMGN as of Q3 2017.

  • Global Endowment Management reported no remaining Amgen position as of Q3 2017 after selling out during the quarter.
  • Global Endowment Management sold 19,700 Amgen shares in Q3 2017, an estimated $3.39M.
  • Global Endowment Management first reported a position in Amgen in Q4 2016 and held it in 2 quarters.
  • Global Endowment Management's Amgen position peaked at $3.39M in Q2 2017.
  • 1,605 funds tracked by Wall St. Rank held Amgen as of Q3 2017.

Based on Global Endowment Management's 13F filing for Q3 2017, filed 13 Nov 2017.